-
Agile Therapeutics NASDAQ:AGRX Agile Therapeutics is a forward-looking women's healthcare company dedicated to fulfilling the unmet health needs of today's women. Its product and product candidates are designed to provide women with contraceptive options that offer freedom from taking a daily pill, without committing to a longer-acting method. The Company's initial product, Twirla®, (levonorgestrel and ethinyl estradiol), a transdermal system, is a non-daily prescription contraceptive. Twirla is based on Company's proprietary transdermal patch technology, called Skinfusion®, which is designed to allow drug delivery through the skin. The Company may occasionally disseminate material, nonpublic information on the Company's website.
Location: 101 Poor Farm Rd, New Jersey, 08540-1941, US | Website: www.agiletherapeutics.com | Industry: Pharmaceutical Preparation Manufacturing | Sector: Manufacturing
Market Cap
NaN
52 Wk Range
$ - $
Previous Close
$N/A
Open
$N/A
Day Range
N/A - N/A
Volume
N/A
Avg Volume
N/A
Enterprise Value
0.00
Cash
0.00
Avg Qtr Burn
N/A
Short % of Float
4.32%
Insider Ownership
9.70%
Institutional Own.
16.02%
Qtr Updated
06/30/24
Drug Pipeline
Powered by
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
| Drug & Indication | Stage & Event | Catalyst Date |
|---|---|---|
Twirla (levonorgestrel and ethinyl estradiol) transdermal system Details Contraceptive, Progestin and estrogen contraception | Approved Quarterly sales | |
AG890 Details Contraceptive, Progestin-only contraception | Phase 2 Update |